Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G. J. Roboz, F. J. Giles, A. F. List, J. E. Cortes, R. Carlin, M. Kowalski, S. Bilic, E. Masson, M. Rosamilia, M. W. Schuster, D. Laurent, E. J. Feldman
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome'. Together they form a unique fingerprint.